RxDoctor Payments Data

Jonathan Borchard, PA

Physician Assistant · Bloom, KSNPI 1578650834

Payments from drug & device makers

$560in general payments, 2019–2025

Across 22 payments — averaging $25.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$160
  • CSL Behring$123
  • Novo Nordisk$92
  • Amgen$69
  • Sanofi$43
  • Vapotherm Inc$23
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$560 in reported general payments places this provider in the 60th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$8,449
Medicare patients
63
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban243$114,757
XareltoRivaroxaban60$53,426
TrulicityDulaglutide48$53,088
OzempicSemaglutide44$52,662
RybelsusSemaglutide39$37,097
MyrbetriqMirabegron36$21,745
EntrestoSacubitril/Valsartan33$17,931
FarxigaDapagliflozin Propanediol23$11,668
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,338
LinzessLinaclotide17$9,625
TradjentaLinagliptin12$6,151
Levothyroxine Sodium391$3,740
Mesalamine11$3,373
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen170$3,043
Potassium Chloride224$2,935

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$92$89,75983 claims
Johnson & JohnsonXarelto$13$53,42660 claims
AstraZenecaFarxiga, Breztri Aerosphere, Pulmicort Flexhaler$160$25,71453 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Bloom

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →